Chart: Pending FDA Guidance Documents For Devices
This article was originally published in The Gray Sheet
You may also be interested in...
The pace at which FDA's device center puts out guidance documents is not adequate, admits CDRH Director Dan Schultz, but it is unlikely to improve anytime soon, he said
Laboratories are urging FDA to once again rework, if not abandon, its proposal to actively regulate certain lab-developed tests, while diagnostics companies are split on the issue
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.